What a compound profile contains.
A section-by-section walkthrough of a profile page, and how to read it quickly without missing the part that matters.
There are 68 compound profiles on this site and they all follow the same structure, so once you can read one you can read all of them. They are also deliberately front-loaded: the two facts that matter most sit above everything else.
The header: grade and status.
Every profile opens with the evidence grade and the regulatory status side by side. Those are different claims. The grade describes how strong the published research is. The status describes whether a regulator has approved the compound, whether it is in registered trials, or whether it is sold for research use only. A compound can have real human data and no approval, and the header refuses to let those blur together.
The axis breakdown.
Below the grade, the six evidence axes are shown with their individual scores, so you can see which inputs produced the letter. This is where the pattern behind most research peptides becomes visible: deep preclinical work, a well-described mechanism, and human evidence near the floor.
Mechanism and what it is claimed to do.
A plain-English account of the pathway, linked to a fuller mechanism explainer. Read this as a reason the compound was worth studying rather than as evidence that it works, which is the substitution most marketing copy relies on.
Claim verdicts.
The specific claims circulating about a compound each get a verdict: holds, partial, too early, unverified, safety caveat, or false. The distinction between unverified and false matters more than any other on this site. Most claims about research peptides are unverified, meaning nobody has run the study, and calling that false would be as dishonest as calling it proven.
Safety and sources.
The safety section reports what is documented, including the cases where what is documented is very little. Then the full source list: roughly 266 citations sit behind the corpus overall, each resolving to a real paper, FDA document, or trial registry, and each checked against the live NCBI record by an automated audit.
If you read only two sections, read the axis breakdown and the claim verdicts. Between them they tell you what is known, what is merely repeated, and how far apart those two things are.
If not, email kam@pepcue.app. For the shorter answers to the questions people ask most, see the FAQ.